{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-071874","form_type":"8-K","ticker":"BRNS","cik":"0001828185","company_name":"Barinthus Biotherapeutics plc.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.641365+00:00","generated_at":"2026-06-25T01:22:42.400926+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vaccitech shareholders re-elect directors, approve auditor and compensation at AGM","bullets":["Re-elected Pierre A. Morgon as director with 15,871,982 for, 1,050 against, 763 withheld.","Re-elected Joseph C.F. Scheeren as director with 15,872,082 for, 1,598 against, 115 withheld.","Appointed PricewaterhouseCoopers LLP as auditors for FY2022 with 15,873,184 for, 601 against.","Approved directors' remuneration policy with 15,871,281 for, 2,404 against, 110 withheld.","Received advisory approval of remuneration report with 15,866,826 for, 1,273 against, 5,696 withheld."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-071874","json":"https://secwatch.observer/filing/0001104659-22-071874.json","markdown":"https://secwatch.observer/filing/0001104659-22-071874.md","text":"https://secwatch.observer/filing/0001104659-22-071874.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828185/000110465922071874/0001104659-22-071874-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828185/000110465922071874/tm2218504d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:22:42.400926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}